Results 201 to 210 of about 249,219 (350)

Enzyme Replacement Therapy in Severe Fabry Disease with Renal Failure: A 1-year Follow-up

, 2004
D. Tsambaos, Elisabeth Chroni, Antonis S. Manolis, Alexandra Monastirli, Efi Pasmatzi, Theophilos Sakkis, Periklis Davlouros, Dimitrios Goumenos, Aggeliki Katrivanou, Sophia Georgiou   +9 more
openalex   +1 more source

Tailoring the Properties of Functional Materials With N‐Oxides

Advanced Functional Materials, EarlyView.
The properties of materials bearing N‐oxide groups are often dominated by the polar N+─O− bond. It provides hydrophilicity, selective ion‐binding, electric conductivity, or antifouling properties. Many of the underlying mechanisms have only recently been discovered, and the interest in N‐oxide materials is rapidly growing.
Timo Friedrich, Michelle Kobus, Shirin Mesgarha, Erica Moretto, Laurens Grosche, Wolfgang Maison   +5 more
wiley   +1 more source

Enzyme replacement therapy for the treatment of late onset Pompe disease: A systematic review and network meta-analysis. [PDF]

Orphanet J Rare Dis
Corbett M, Umemneku-Chikere C, Nevitt S, Deng NJ, Walton M, Fulbright H, Tan CY, Lachmann R, Churchill R, Hodgson R.   +9 more
europepmc   +1 more source

Fabry disease: Kidney involvement and enzyme replacement therapy

, 2004
Kostas C. Siamopoulos
openalex   +1 more source

Clinical benefit of enzyme replacement therapy in Fabry disease [PDF]

, 2006
Frank Breunig, Frank Weidemann, Jörg Strotmann, Anita Knoll, Christoph Wanner   +4 more
openalex   +1 more source

Electrosynthesis of Bioactive Chemicals, From Ions to Pharmaceuticals

Advanced Functional Materials, EarlyView.
This review discusses recent advances in electrosynthesis for biomedical and pharmaceutical applications. It covers key electrochemical materials enabling precise delivery of ions and small molecules for cellular modulation and disease treatment, alongside catalytic systems for pharmaceutical synthesis.
Gwangbin Lee, Sojin Kim, Myeongeun Lee, Kyoungsuk Jin, Jimin Park   +4 more
wiley   +1 more source

Pancreatic enzyme replacement therapy can improve infection level nutrition condition and prognosis of patients with sepsis. [PDF]

Food Nutr Res
Zhao L, Wang S.
europepmc   +1 more source

Enzyme replacement therapy administered during hemodialysis in patients with Fabry disease

, 2004
Markus Kosch, Hans-Georg Koch, João Paulo Oliveira, Carlos Soares, Francesco Bianco, Frank Breuning, Åse Krogh Rasmussen, Roland M. Schaefer   +7 more
openalex   +1 more source

Vestibular and auditory deficits in Fabry disease and their response to enzyme replacement therapy [PDF]

, 2007
Antonio Palla, Stefan Hegemann, Urs Widmer, Dominik Straumann   +3 more
openalex   +1 more source

Controlled Release of Human Dental Pulp Stem Cell‐Derived Exosomes from Hydrogels Attenuates Temporomandibular Joint Osteoarthritis

Advanced Healthcare Materials, EarlyView.
Exosomes can reduce tissue damage in temporomandibular joint osteoarthritis (TMJOA), but rapid clearance limits their efficacy. This study encapsulates exosomes in hyaluronic acid hydrogels for controlled release. In a rat model, hydrogel‐encapsulated exosomes outperform free exosomes in preserving bone integrity and reducing tissue destruction ...
Victor Diez‐Guardia, Yajing Tian, Yunzhe Guo, Jiaying Li, Shengjie Cui, Cécile A. Dreiss, Eileen Gentleman, Xuedong Wang   +7 more
wiley   +1 more source